GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Ending Cash Position

ANTCF (Aion Therapeutic) Ending Cash Position : $0.07 Mil (As of Oct. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aion Therapeutic Ending Cash Position?

Aion Therapeutic's Ending Cash Position for the quarter that ended in Oct. 2024 was $0.07 Mil.

Aion Therapeutic's quarterly Ending Cash Position increased from Apr. 2024 ($0.05 Mil) to Jul. 2024 ($0.06 Mil) and increased from Jul. 2024 ($0.06 Mil) to Oct. 2024 ($0.07 Mil).

Aion Therapeutic's annual Ending Cash Position stayed the same from Apr. 2022 ($0.00 Mil) to Apr. 2023 ($0.00 Mil) but then increased from Apr. 2023 ($0.00 Mil) to Apr. 2024 ($0.05 Mil).

Aion Therapeutic Ending Cash Position Historical Data

The historical data trend for Aion Therapeutic's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Ending Cash Position Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Ending Cash Position
Get a 7-Day Free Trial 0.44 0.19 - - 0.05

Aion Therapeutic Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.26 0.05 0.06 0.07

Aion Therapeutic Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Aion Therapeutic's Ending Cash Position for the fiscal year that ended in Apr. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.3877787807814E-17+0.05
=0.05

Aion Therapeutic's Ending Cash Position for the quarter that ended in Oct. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.059+0.009
=0.07

Aion Therapeutic Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (OTCPK:ANTCF) » Definitions » Ending Cash Position
Comparable Companies
TSXV:MPH TSXV:DHB XCNQ:BBM TSXV:CANB XCNQ:AYUR TSX:WLLW XCNQ:IMCC XCNQ:HERB NEOE:FH XCNQ:OILS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
AION:Canada
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Website
https://www.aiontherapeutic.com
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.